A common MET polymorphism harnesses HER2 signaling to drive aggressive squamous cell carcinoma.

MLA

Kong, Li Ren, et al. “A Common MET Polymorphism Harnesses HER2 Signaling to Drive Aggressive Squamous Cell Carcinoma.” Nature Communications, vol. 11, no. 1, Mar. 2020, pp. 1–14. EBSCOhost, https://doi.org/10.1038/s41467-020-15318-5.

APA

Kong, L. R., Mohamed Salleh, N. A. B., Ong, R. W., Tan, T. Z., Syn, N. L., Goh, R. M., Fhu, C. W., Tan, D. S. W., Iyer, N. G., Kannan, S., Verma, C. S., Lim, Y. C., Soo, R., Ho, J., Huang, Y., Lim, J. S. J., Yan, B. J., Nga, M. E., Lim, S. G., & Koeffler, H. P. (2020). A common MET polymorphism harnesses HER2 signaling to drive aggressive squamous cell carcinoma. Nature Communications, 11(1), 1–14. https://doi.org/10.1038/s41467-020-15318-5

Chicago

Kong, Li Ren, Nur Afiqah Binte Mohamed Salleh, Richard Weijie Ong, Tuan Zea Tan, Nicholas L. Syn, Robby Miguel Goh, Chee Wai Fhu, et al. 2020. “A Common MET Polymorphism Harnesses HER2 Signaling to Drive Aggressive Squamous Cell Carcinoma.” Nature Communications 11 (1): 1–14. doi:10.1038/s41467-020-15318-5.